NCT03728465 Evaluation of Safety and Efficacy of Patients With Four and More Symptomatic Brain Metastases of Melanoma Status TERMINATED Phase PHASE2
NCT03726359 Phase I Study of Fractionated Stereotactic Radiation Therapy Status RECRUITING Phase PHASE1
NCT03714243 Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases Status COMPLETED Phase NA
NCT03698162 Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases Status TERMINATED Phase NA
NCT03653546 First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) Metastases Status COMPLETED Phase PHASE2/PHASE3
NCT03638765 Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer Status UNKNOWN Phase PHASE1
NCT03626818 The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy Status UNKNOWN Phase N/A
NCT03550391 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases Status RECRUITING Phase PHASE3
NCT03525301 Short Course Radiation Therapy in Palliative Treatment of Brain Metastases Status UNKNOWN Phase NA
NCT03520829 Protocol for Evaluating a Planning Algorithm for Gamma Knife Radiosurgery Status UNKNOWN Phase N/A
NCT03508752 Neurocognitive Decline in Patients With Brain Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03488472 Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain Status TERMINATED Phase NA
NCT03458455 Improved Therapy Response Assessment in Metastatic Brain Tumors Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03449238 Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients Status RECRUITING Phase PHASE1/PHASE2
NCT03430947 Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases Status TERMINATED Phase PHASE2
NCT03414944 Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases Status UNKNOWN Phase NA